
Chengdu
688319.SSChengdu Olymvax Biopharmaceuticals Inc. Price (688319.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
405,440,226
(0.0432)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Olymvax Biopharmaceuticals Inc. develops and supplies vaccines. The company offers vaccines for Tetanus, a deadly infectious disease that causes nervous system toxicity by toxigenic clostridium tetanus; and haemophilus influenzae type b. it also develops vaccines for Staphylococcus aureus, a pathogenic bacterium that causes hospital infection and community infection; and Group A streptococcus disease. The company was founded in 2009 and is based in Chengdu, China. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $7.06-16.15
- Market Cap 6.03B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Mr. Shaowen Fan
- IPO Date: June, 08, 2021
- Country: CN
- Currency: CNY
- Headquaters: No Data
- Employees: 471
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
